Shares of Kinaxis Inc. (TSE:KXS - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the six research firms that are currently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is C$216.43.
KXS has been the topic of several analyst reports. Royal Bank Of Canada upped their target price on Kinaxis from C$225.00 to C$235.00 in a report on Friday, August 8th. Scotiabank upped their target price on Kinaxis from C$225.00 to C$240.00 and gave the stock an "outperform" rating in a report on Friday, August 8th. Finally, Stifel Nicolaus upped their target price on Kinaxis from C$225.00 to C$245.00 and gave the stock a "buy" rating in a report on Thursday, July 31st.
Read Our Latest Report on Kinaxis
Kinaxis Stock Performance
Shares of Kinaxis stock opened at C$187.00 on Tuesday. The company has a debt-to-equity ratio of 12.12, a current ratio of 1.89 and a quick ratio of 2.29. The stock's 50-day moving average is C$196.57 and its 200-day moving average is C$186.97. The firm has a market cap of C$5.29 billion, a price-to-earnings ratio of 217.44, a price-to-earnings-growth ratio of 3.60 and a beta of 0.93. Kinaxis has a one year low of C$149.96 and a one year high of C$212.45.
Insider Buying and Selling
In other Kinaxis news, Senior Officer Michael David Mauger sold 1,310 shares of the company's stock in a transaction that occurred on Monday, June 23rd. The stock was sold at an average price of C$198.66, for a total value of C$260,242.24. Also, Director Angel Luis Mendez sold 6,100 shares of the company's stock in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of C$190.00, for a total value of C$1,159,000.00. Following the completion of the sale, the director owned 1,400 shares in the company, valued at C$266,000. This represents a 81.33% decrease in their position. Over the last ninety days, insiders have sold 9,966 shares of company stock worth $1,925,449. Insiders own 1.20% of the company's stock.
Kinaxis Company Profile
(
Get Free Report)
Kinaxis Inc is a Canada-based provider of software solutions for sales and operations planning (S&OP) and supply chain management. The firm's flagship RapidResponse product is offered on the cloud. Its capabilities include consequence evaluation and alerting, responsibility-based collaboration, high-speed analytics, and scenario simulation.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kinaxis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.
While Kinaxis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.